Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Are You Watching Atlantic American (NASDAQ:AAME) Penny Stock After a 16% Slide on Its Nasdaq Delisting Determination?

Atlantic American (NASDAQ:AAME) shares fell 15.79% to $1.33 on Friday, October 23, 2026. The decline followed a company announcement dated October 22, 2026, that Nasdaq had issued a Staff Delisting Determination.

Vinay Lochav | 23 October 2026

Are You Watching authID (NASDAQ:AUID) Penny Stock After a 14% Drop and a $1.35 Million Financing?

authID (NASDAQ:AUID) shares fell 14.02% to $0.3018 on Friday, October 23, 2026, during the regular session. The company has not announced a catalyst for the decline, and its latest release is a financing announced on October 5, 2026.

Vinay Lochav | 23 October 2026

Why Is BIO-key (NASDAQ:BKYI) Penny Stock Up 29% as Its Nasdaq Return Meets a Narrower Loss?

BIO-key (NASDAQ:BKYI) shares rose 29.19% to $3.54 on Friday, October 23, 2026. The company has not announced a catalyst for the session, and its latest dated disclosure is its second-quarter report from August 13.

Vinay Lochav | 23 October 2026

Biotech Stocks Falling: Do Cash and Pipeline Explain Tango Therapeutics (NASDAQ:TNGX), Phathom Pharmaceuticals (NASDAQ:PHAT) and More?

Aardvark Therapeutics (NASDAQ:AARD) fell 43.04% to $2.25 after exploratory data from its terminated Phase 3 HERO trial, and Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) dropped 28.60% to $0.3495 with no announced catalyst. MacroGenics (NASDAQ:MGNX) lost 20.11% to $2.90 on the day of a scheduled poster, Phathom Pharmaceuticals …

Vinay Lochav | 23 October 2026

Biotech Penny Stock Gainers: Are Lucid Diagnostics (NASDAQ:LUCD), Estrella Immunopharma (NASDAQ:ESLA) and More Running Ahead of Catalysts?

Five healthcare small caps advanced on Friday, October 23, 2026. Lucid Diagnostics (NASDAQ:LUCD) rose 24.41% to $0.4077 after announcing first Medicare payments of $1,938.01 per EsoGuard test, while Estrella Immunopharma (NASDAQ:ESLA) gained 11.24% to $0.8085 with its lymphoma trial adding sites. Tvardi Therapeutics (NASDAQ:TVRD) …

Vinay Lochav | 23 October 2026

Despite Lower Output, Why Is BitFuFu (NASDAQ:FUFU) Penny Stock Up 8% With Bitcoin Holdings Rising?

BitFuFu (NASDAQ:FUFU) shares rose 8.28% to $1.08 in the regular session on Friday, October 23, 2026. The company has not announced a catalyst for the move, and its latest disclosure is the September operating update released on October 13, 2026.

Vinay Lochav | 23 October 2026

What Is Behind the 8% Rise in BitVentures (NASDAQ:BVC) Stock After Its Pivot to Crypto Mining?

BitVentures (NASDAQ:BVC) shares gained 8.11% to $13.46 in the regular session on Friday, October 23, 2026. The company has not announced a catalyst for the move, and its most recent results cover the six months ended December 31, 2025.

Vinay Lochav | 23 October 2026

Is Bradbury Capital (NASDAQ:BBCI) Penny Stock a Fast Faller After Its October Nasdaq Debut?

Bradbury Capital (NASDAQ:BBCI) shares fell 9.27% to $1.86 on Friday, October 23, 2026, in regular trading. The company has not announced a catalyst for the decline. The stock sits about 13.5% below the $2.15 quote seen on October 21 (calculated).

Vinay Lochav | 23 October 2026

Dividend and Buyback Stocks: Are Robert Half (NYSE:RHI), Selective Insurance (NASDAQ:SIGI) and More Rewarding Shareholders After Fresh Results?

Six companies returned or committed cash to shareholders, and five of their stocks rose on Friday, October 23, 2026. Robert Half (NYSE:RHI) jumped 15.21% to $43.41 with a $0.59 quarterly dividend and slower repurchases, while Selective Insurance (NASDAQ:SIGI) rose 9.43% to $100.39 after a …

Vinay Lochav | 23 October 2026

Going Concern Stocks: Is Thin Cash Behind Mediaco Holding (NASDAQ:MDIA), Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) and More?

Five companies combine small cash balances with financing pressure in filings, based on the figures each has disclosed through October 23, 2026. Mediaco Holding (NASDAQ:MDIA) rose 8.71% to $1.12 with $1.81 million of cash and a going concern warning. Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) fell 28.60% …

Vinay Lochav | 23 October 2026
Support

Hi! How can we help you today?

Loading…